Novel echocardiographic parameters in pulmonary hypertension assessment and the relationship between echocardiography and 6-minute walking test

Leila Bigdelu,Hedieh Alimi,Afsoon Fazlinezhad,Fereshteh Ghaderi,Hoorak Poorzand,Farveh Vakilian,Faeze Keihanian,Zahra Abbasi Shaye,Sara Afshar
DOI: https://doi.org/10.1097/md.0000000000035294
IF: 1.6
2024-02-10
Medicine
Abstract:Pulmonary arterial hypertension (PAH) is defined as mean pulmonary arterial pressure (mPAP) ≥25 mm Hg at rest. [ 1 ] PAH is a progressive disorder that primarily results from extensive pulmonary vascular remodeling over time. [ 2 ] PAH is a complex disorder and can be the end result of a variety of different underlying disorders. Pulmonary artery stiffness (PAS) is a strong determinant of right ventricular (RV) functions. [ 3 ] PAS is mainly due to endothelial dysfunction and inflammation. [ 4 ] Elevated PAS leads to a higher right ventricle workload and enhances transmission to small pulmonary vessels, which results in further vascular damage. [ 1 , 5 ] Increased stiffness is associated with reduced functional capacity [ 6 ] and higher mortality. [ 7 ] This association is independent of pulmonary artery pressures or pulmonary vascular resistance. [ 7 ] So far, PAS and response to treatment have been assessed through invasive hemodynamic assessment. [ 8–10 ] Noninvasive imaging modalities have also been used to measure PA distensibility for the assessment of pulmonary artery (PA) stiffness and risk stratification in patients with PAH. [ 11 ] Many studies demonstrate that PAS is correlated with RV dysfunction and disease severity in PAH regardless of the etiology. [ 12 , 13 ]
medicine, general & internal
What problem does this paper attempt to address?